Audio Podcasts
- email
Thanks for emailing that article!
Listen to these audio recordings of conversations with the scientists funded by Glaucoma Research Foundation who are working to find a cure.
President's Teleconference with Dr. Andrew Huberman
Topic: "Neurons: The Canary in the Coal Mine" In this recorded Glaucoma Research Foundation teleconference from May 2, 2013, President and CEO Thomas M. Brunner talks with Andrew Huberman, PhD from the University of California San Diego. Dr. Huberman is a Principal Investigator in the Catalyst for a Cure research consortium funded by Glaucoma Research Foundation.
President's Teleconference with Dr. Monica Vetter
Topic: "Biomarkers in Glaucoma." In this recorded Glaucoma Research Foundation teleconference from December 6, 2012, President and CEO Thomas M. Brunner talks with Monica Vetter, PhD from the University of Utah. Dr. Vetter is a Principal Investigator in the Catalyst for a Cure research consortium funded by Glaucoma Research Foundation.
President's Teleconference with Dr. Jeffrey Goldberg
Topic: "Discovering Glaucoma Biomarkers Can Lead to a Cure." In this recorded Glaucoma Research Foundation teleconference from May 17, 2012, President and CEO Thomas M. Brunner talks with Jeffrey Goldberg, MD, PhD from the Bascom Palmer Eye Institute at the University of Miami. Dr. Goldberg is a Principal Investigator in the Catalyst for a Cure research consortium funded by Glaucoma Research Foundation.
President's Teleconference with Dr. David Calkins
Topic: "Catalyst For a Cure - New Directions." Glaucoma Research Foundation President and CEO Thomas M. Brunner talks with David Calkins, PhD, Vice-Chairman and Director for Research at Vanderbilt University, and Principal Investigator in the Catalyst For a Cure research consortium. This President's Teleconference took place on December 8, 2011.
President's Teleconference with Dr. Monica Vetter
Topic: "What Triggers Nerve Damage in Glaucoma?" Glaucoma Research Foundation President and CEO Thomas M. Brunner hosts a conversation with Monica Vetter, PhD, Principal Investigator in the Catalyst For a Cure research consortium. The teleconference was recorded December 9, 2010. Dr. Vetter is Neurobiology and Anatomy Department Chair and George and Lorna Winder Professor of Neuroscience at the University of Utah, Salt Lake City, Utah.
Last reviewed on May 03, 2013
